3D ¼¼Æ÷¹è¾ç ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ : ±â¼úº°, ¿ëµµº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2025-2030³â)
3D Cell Culture Market Size, Share & Trends Analysis Report By Technology (Scaffold Based, Scaffold Free), By Application (Stem Cell Research & Tissue Engineering, Cancer Research), By End-use, By Region, And Segment Forecasts, 2025 - 2030
»óǰÄÚµå : 1630951
¸®¼­Ä¡»ç : Grand View Research, Inc.
¹ßÇàÀÏ : 2024³â 12¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 140 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,950 £Ü 8,609,000
Unprintable PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,950 £Ü 10,055,000
Printable PDF (5-User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,950 £Ü 12,949,000
Printable PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

3D ¼¼Æ÷¹è¾ç ½ÃÀå ¼ºÀå°ú µ¿Çâ:

Grand View Research, IncÀÇ ÃֽŠº¸°í¼­¿¡ µû¸£¸é, Àü ¼¼°è 3D ¼¼Æ÷¹è¾ç ½ÃÀå ±Ô¸ð´Â 2025³âºÎÅÍ 2030³â±îÁö ¿¬Æò±Õ 11.72%ÀÇ CAGRÀ» ±â·ÏÇϸç 2030³â¿¡´Â 32¾ï 1,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ü¿Ü °Ë»ç ¸ðµ¨ÀÇ ±â¼ú ¹ßÀü, ¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ °ü½É Áõ°¡, Á¤ºÎÀÇ ¿¬±¸ °³¹ß Áö¿ø¹ý µîÀÌ ÀÌ ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¸¸¼ºÁúȯÀÇ À¯º´·ü Áõ°¡¿Í ¼¼Æ÷ Ä¡·áÀÇ Á߿伺ÀÌ ³ô¾ÆÁö¸é¼­ ¾÷°è ¼ºÀåÀÇ ¸ð¸àÅÒÀ» âÃâÇϰí ÀÖ½À´Ï´Ù.

Á¶Á÷°øÇÐÀº ±âÁ¸ÀÇ 2D ¼¼Æ÷¹è¾çº¸´Ù »ýü ³» ¹è¾ç ¹èÁö¸¦ º¸´Ù Á¤È®ÇÏ°Ô ¸ð¹æÇÑ 3D ¹è¾ç ¸ðµ¨ Á¦ÀÛ¿¡ ÀÖ¾î Å« ¹ßÀüÀ» ÀÌ·ç¾ú½À´Ï´Ù. ±× °á°ú, µ¶¼º ½ÃÇè, ½Å¾à°³¹ß, Àç»ýÀÇ·á °³¹ß¿¡ 3D ¼¼Æ÷¹è¾ç ½Ã½ºÅÛÀÇ È°¿ëÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÃÖ±Ù ¾÷°è ¾÷üµéÀÇ ÀÕµû¸¥ Á¦Ç° Ãâ½Ãµµ ½ÃÀå ¼ºÀå¿¡ Å« ÈûÀ» º¸Å°í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2023³â 6¿ù Pixelgen Technologies´Â ¼¼Æ÷ Ç¥¸é¿¡ Á¸ÀçÇÏ´Â ´Ü¹éÁúÀÇ 3D °ø°£ ¿¬±¸¸¦ À§ÇÑ ÃÖÃÊÀÇ ºÐÀÚ Çȼ¿È­ ŰƮ¸¦ Ãâ½ÃÇß½À´Ï´Ù.

¶ÇÇÑ, ¹Ì¼¼À¯Ã¼°øÇÐ, ¹ÙÀÌ¿ÀÇÁ¸°ÆÃ, °íÇÔ·® ½ºÅ©¸®´× ½Ã½ºÅÛ°ú °°Àº ÷´Ü ±â¼úÀÇ °³¹ßÀÌ ÀÌ·¯ÇÑ ¸ðµ¨ÀÇ ´É·ÂÀ» Ȱ¿ëÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼úµéÀº ¹è¾ç Á¶°Ç, ¼¼Æ÷ Á¶Á÷, °íÈ¿À² ½ºÅ©¸®´× ¼öÇà ´É·Â¿¡ ´ëÇÑ ¿ì¼öÇÑ Á¦¾î°¡ °¡´ÉÇÏ¿© 3D ¹è¾ç ½Ã½ºÅÛÀÇ È°¿ëÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¹è¾ç ¸ðµ¨ °³¹ß¿¡ ¹ÙÀÌ¿ÀÇÁ¸°ÆÃ ¹× ¹Ì¼¼À¯Ã¼ ±â¼úÀ» Ȱ¿ëÇϱâ À§ÇÑ ½ÃÀå °ü°èÀÚµé °£ÀÇ Çù·Â °ü°è °­È­°¡ ½ÃÀå ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, AIM Biotech¿Í MatTekÀº 2023³â 6¿ù¿¡ Á¦ÈÞÇÏ¿© ½Å°æ»ý¹°ÇÐ, ¸é¿ªÁ¾¾çÇÐ, Ç÷°ü»ý¹°ÇÐ µî ƯÁ¤ ºÐ¾ß¿¡¼­ Çõ½ÅÀûÀÎ idenTX ¹× organiX ¹Ì¼¼À¯Ã¼ 3D Á¶Á÷¹è¾ç Ç÷§Æû°ú ÇÔ²² ¿Ïº®ÇÑ ½Å¾à°³¹ß ¿¬±¸ ¼­ºñ½º¸¦ Á¦°øÇϰí ÀÖ½À´Ï´Ù.

3D ¹è¾çÀº Àå±âÀÇ ÀüÇüÀûÀÎ ¹Ì¼¼±¸Á¶¿Í ÇüŸ¦ Ãæ½ÇÇÏ°Ô ÀçÇöÇÒ ¼ö Àֱ⠶§¹®¿¡ üÁ¶Á÷À̳ª Àå±â¿¡ ´ëÇÑ ¾à¹°ÀÇ È¿°ú¸¦ ºÐ¼®Çϱâ À§ÇØ in vivo ¸ðµ¨À» ÇÊ¿ä·Î ÇÏ´Â ¿¬±¸¸¦ À§ÇØ Áö¼ÓÀûÀ¸·Î °³¹ßµÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀÎÀº ´Ù¾çÇÑ Ã¼¿Ü Àû¿ëÀ» À§ÇÑ ½ºÄ³Æú´õÀÇ Àç·á ¹× ±¸Á¶ Ãø¸é¿¡¼­ ¿©·¯ °¡Áö ¼±ÅÃÀÌ °¡´ÉÇÏ´Ù´Â Á¡°ú ÇÔ²² ½ºÄ³Æú´õÀÇ ¼öÀͼºÀ» ³ôÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÃÖ±Ù ¿¬±¸¿¡ µû¸£¸é, ±×·¡ÇÉ ºñ°è, ³ª³ë¼¶À¯, õ¿¬ ÇØ¾ç Äݶó°Õ, ³Ãµ¿ ÁÖÁ¶ µî ´Ù¾çÇÑ ºñ°èÀÇ »ç¿ëÀÌ °ËÅäµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Áõ½Ä, ÀÚ±Ø, »ýÁ¸À², ¼ö¼Û, °íÇÔ·® ½ºÅ©¸®´×, ÆÐÄ¡ Ŭ·¥ÇÎ, ´ë»ç Ȱ¼º µî ¿©·¯ Á¾·ùÀÇ ºÐ¼®¿¡¼­ ·¦¿ÂĨ°ú °°Àº ±â¼úÀÇ »õ·Î¿î Àû¿ëÀº °í±Þ ¹× È¿À²ÀûÀÎ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡·Î À̾îÁú °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

±×·¯³ª 3D ¼¼Æ÷ ¸ðµ¨ Á¦Ç°ÀÇ Àϰü¼º ºÎÁ·Àº ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÁÖ¿ä ´ÜÁ¡ Áß ÇϳªÀÔ´Ï´Ù. ¶ÇÇÑ, ¼¼Æ÷¹è¾çÀÇ ÆíÂ÷, Ç¥ÁØÈ­ ¹®Á¦, ±Ô¸ð ¹× Á¦Á¶ ¹®Á¦, ǰÁú °ü¸® ¹®Á¦ µî ´Ù¾çÇÑ ¿äÀεéÀÌ ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

3D ¼¼Æ÷¹è¾ç ½ÃÀå : ºÐ¼® °³¿ä

¸ñÂ÷

Á¦1Àå ºÐ¼® ¹æ¹ý¡¤¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå º¯¼ö, µ¿Çâ, ¹üÀ§

Á¦4Àå »ç¾÷ ºÐ¼® : ±â¼úº°

Á¦5Àå »ç¾÷ ºÐ¼® : ¿ëµµº°

Á¦6Àå ÃÖÁ¾ ¿ëµµ ºñÁî´Ï½º ºÐ¼®

Á¦7Àå »ç¾÷ ºÐ¼® : Áö¿ªº°

Á¦8Àå °æÀï ±¸µµ

KSM
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

3D Cell Culture Market Growth & Trends:

The global 3D cell culture market size is expected to reach USD 3.21 billion by 2030, registering a CAGR of 11.72% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is driven by technological advancements in in-vitro testing models, a rising focus on personalized medicine, and supportive government legislation for R&D. Moreover, the increasing prevalence of chronic disorders, and the growing significance of cell therapies in their treatment have created momentum for industry expansion.

Tissue engineering has made significant developments in creating 3D culture models that mimic the in-vivo culture media more precisely than the conventional 2D cell cultures. This resulted in increased utilization of 3D cell culture systems for toxicity testing, drug discovery, and regenerative medicine development. Also, recent product launches from industry players have supported market growth to a significant extent. For instance, in June 2023, Pixelgen Technologies launched its first molecular pixelation kit for 3D spatial study of proteins present on cell surface.

In addition, the development of advanced technologies like microfluidics, bioprinting, and high-content screening systems, has leveraged the capabilities of these models. These technologies allow excellent control over culture conditions, cell organization, and the capability to perform high-efficiency screening, thereby fueling the utilization of 3D culture systems. Moreover, increased collaboration between market players to utilize bioprinting and microfluidics techniques in developing culture models has propelled market growth. For instance, in June 2023, AIM Biotech and MatTek partnered together to offer innovative idenTX and organiX microfluidic 3D tissue culture platforms along with complete drug discovery research services in specific areas of neurobiology, immune-oncology, and vascular biology.

3D cultures can closely replicate the typical microarchitecture and morphology of organs and hence are continuously developed for studies that require in vivo models to analyze the effect of a drug over body tissues and organs. This factor, coupled with the availability of several choices in terms of the material and structure of the scaffold for a variety of in-vitro applications, is anticipated to boost revenue generation for scaffolds. Recent research has explored the use of a broad range of scaffolds, such as graphene scaffolds, nanofibers, natural marine collagen, freeze-casting, and others. In addition, emerging applications of techniques such as lab-on-a-chip in several assay types, including proliferation, stimulation, viability, transport, high content screening, patch clamping, and metabolic activity are anticipated to lead to an increase in demand for advanced and efficient solutions.

However, the lack of consistency in 3D cell model products is one of the major drawbacks that is expected to hinder the growth of the market. Moreover, various factors such as variability in cell culture, standardized challenges, scale & manufacturing issues, and quality control issues might hamper the market growth.

3D Cell Culture Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Market Variables, Trends, & Scope

Chapter 4. Technology Business Analysis

Chapter 5. Application Business Analysis

Chapter 6. End Use Business Analysis

Chapter 7. Regional Business Analysis

Chapter 8. Competitive Landscape

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â